美国平价减肥药供应商HIMS四季度利润欠佳,加重投资者对GLP-1业务的顾虑

老虎资讯综合
25 Feb

美国平价减肥药供应商 Hims & Hers Health Inc. 四季度EPS为0.11美元,2023年同期0.01美元。

  • 四季度营收4.811亿美元,分析师预期4.704亿美元。

  • 四季度净订单281万,分析师预期290万。

  • 四季度平均订单价值168美元,分析师预期157.50美元。

  • 四季度运营开支3.509亿美元,同比增长72%。

  • 预计2025年营收23.0亿-24.0亿美元,分析师预期20.9亿美元。

  • 预计一季度营收5.20亿-5.40亿美元,分析师预期4.825亿美元。

  • 预计一季度调整后EBITDA为0.55亿-0.65亿美元,分析师预期0.569亿美元。

  • 预计2025年减肥药业务营收至少将达到7.25亿美元。

Hims & Hers(HIMS)美股盘后跌18%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10